Bayer and Atara Biotherapeutics enter strategic collaboration for mesothelian-targeted CAR T-cell therapies for solid tumors
Agreement is fundamental element of Bayer’s new Cell & Gene Therapy strategy Bayer to enter CAR T-cell therapy space and expand oncology development pipeline with groundbreaking technology Recognizes the leading position of Atara’s technology platform in allogeneic cell therapy Collaboration will focus